Shenzhen YHLO Biotech Co., Ltd. Stock

Equities

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
24.03 CNY +2.08% Intraday chart for Shenzhen YHLO Biotech Co., Ltd. +14.37% +5.07%
Sales 2024 * 2.27B 314M Sales 2025 * 2.79B 385M Capitalization 13.66B 1.88B
Net income 2024 * 476M 65.69M Net income 2025 * 630M 86.95M EV / Sales 2024 * 6.01 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.89 x
P/E ratio 2024 *
28.7 x
P/E ratio 2025 *
21.7 x
Employees 1,837
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.98%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.08%
1 week+14.37%
Current month-1.11%
1 month-1.68%
3 months+5.86%
6 months+23.04%
Current year+5.07%
More quotes
1 week
20.83
Extreme 20.83
24.08
1 month
20.83
Extreme 20.83
25.30
Current year
19.91
Extreme 19.91
26.60
1 year
15.31
Extreme 15.31
26.60
3 years
15.31
Extreme 15.31
52.71
5 years
15.31
Extreme 15.31
52.71
10 years
15.31
Extreme 15.31
52.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 09-12-31
Chairman 46 12-11-30
Chairman 33 12-11-30
Members of the board TitleAgeSince
Director/Board Member 54 23-10-09
Chairman 33 12-11-30
Chief Executive Officer 40 09-12-31
More insiders
Date Price Change Volume
24-04-26 24.03 +2.08% 2,742,177
24-04-25 23.54 -1.05% 1,919,494
24-04-24 23.79 +3.93% 5,025,383
24-04-23 22.89 +1.78% 3,454,060
24-04-22 22.49 +7.04% 6,232,775

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
24.03 CNY
Average target price
28.67 CNY
Spread / Average Target
+19.30%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688575 Stock